Collectively , findings suggest that yogic practice s may promote significant improvements in several indices of importance in DM2 management , including glycemic control , lipid levels , and body composition .
More limited data suggest that yoga may also lower oxidative stress and blood pressure ; enhance pulmonary and autonomic function , mood , sleep , and quality of life ; and reduce medication use in adults with DM2 .
A growing body of evidence suggests yogic practice s may benefit adults with type 2 diabetes ( DM2 ) .
In this systematic review , we evaluate available evidence from prospect i ve controlled trials regarding the effects of yoga-based programs on specific health outcomes pertinent to DM2 management .
Cardiac autonomic function in patients with diabetes improves with practice of comprehensive yogic breathing program
Background : The aim of this study was to observe the effect comprehensive yogic breathing ( Sudarshan Kriya Yoga [ SKY ] and Pranayam ) had on cardiac autonomic functions in patients with diabetes . Material s and Methods : This is a prospect i ve r and omized controlled intervention trial . Cardiac autonomic functions were assessed in 64 diabetics . Patients were r and omized into two groups , one group receiving st and ard therapy for diabetes and the other group receiving st and ard therapy for diabetes and comprehensive yogic breathing program . St and ard therapy included dietary advice , brisk walking for 45 min daily , and administration of oral antidiabetic drugs . Comprehensive yogic breathing program was introduced to the participants through a course of 12 h spread over 3 days . It was an interactive session in which SKY , a rhythmic cyclical breathing , preceded by Pranayam is taught under the guidance of a certified teacher . Cardiac autonomic function tests were done before and after 6 months of intervention . Results : In the intervention group , after practicing the breathing techniques for 6 months , the improvement in sympathetic functions was statistically significant ( P 0.04 ) . The change in sympathetic functions in the st and ard therapy group was not significant ( P 0.75 ) . Parasympathetic functions did not show any significant change in either group . When both parasympathetic and sympathetic cardiac autonomic functions were considered , there was a trend toward improvement in patients following comprehensive yogic breathing program ( P 0.06 ) . In the st and ard therapy group , no change in cardiac autonomic functions was noted ( P 0.99 ) . Conclusion : Cardiac autonomic functions improved in patients with diabetes on st and ard treatment who followed the comprehensive yogic breathing program compared to patients who were on st and ard therapy alone
Collectively , findings suggest that yogic practice s may promote significant improvements in several indices of importance in DM2 management , including glycemic control , lipid levels , and body composition .
More limited data suggest that yoga may also lower oxidative stress and blood pressure ; enhance pulmonary and autonomic function , mood , sleep , and quality of life ; and reduce medication use in adults with DM2 .
A growing body of evidence suggests yogic practice s may benefit adults with type 2 diabetes ( DM2 ) .
In this systematic review , we evaluate available evidence from prospect i ve controlled trials regarding the effects of yoga-based programs on specific health outcomes pertinent to DM2 management .